Tumour-derived PGD2 and NKp30-B7H6 engagement drives an immunosuppressive ILC2-MDSC axis
Group 2 innate lymphoid cells (ILC2s) modulate inflammatory and allergic responses, but their function in cancer immunity is still unclear. Here the authors show that, in acute promyelocytic leukaemia, tumour-activated ILC2s secrete IL-13 to induce myeloid-derived suppressor cells and support tumour...
Guardado en:
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/acd6edf30f5b42e78199d6bb93f923c9 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:acd6edf30f5b42e78199d6bb93f923c9 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:acd6edf30f5b42e78199d6bb93f923c92021-12-02T17:01:24ZTumour-derived PGD2 and NKp30-B7H6 engagement drives an immunosuppressive ILC2-MDSC axis10.1038/s41467-017-00678-22041-1723https://doaj.org/article/acd6edf30f5b42e78199d6bb93f923c92017-09-01T00:00:00Zhttps://doi.org/10.1038/s41467-017-00678-2https://doaj.org/toc/2041-1723Group 2 innate lymphoid cells (ILC2s) modulate inflammatory and allergic responses, but their function in cancer immunity is still unclear. Here the authors show that, in acute promyelocytic leukaemia, tumour-activated ILC2s secrete IL-13 to induce myeloid-derived suppressor cells and support tumour growth.Sara TrabanelliMathieu F. ChevalierAmaia Martinez-UsatorreAlejandra Gomez-CadenaBérengère SaloméMariangela LeccisoValentina SalvestriniGrégory VerdeilJulien RacleCristina PapayannidisHideaki MoritaIrene PizzitolaCamille GrandclémentPerrine BohnerElena BruniMukul GirotraRani PallaviPaolo FalvoElisabeth Oppliger LeibundgutGabriela M. BaerlocherCarmelo Carlo-StellaDaniela TaurinoArmando SantoroOrietta SpinelliAlessandro RambaldiEmanuela GiarinGiuseppe BassoCristina TresoldiFabio CiceriDavid GfellerCezmi A. AkdisLuca MazzarellaSaverio MinucciPier Giuseppe PelicciEmanuela MarcenaroAndrew N. J. McKenzieDominique VanheckeGeorge CoukosDomenico MavilioAntonio CurtiLaurent DerréCamilla JandusNature PortfolioarticleScienceQENNature Communications, Vol 8, Iss 1, Pp 1-14 (2017) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Science Q |
spellingShingle |
Science Q Sara Trabanelli Mathieu F. Chevalier Amaia Martinez-Usatorre Alejandra Gomez-Cadena Bérengère Salomé Mariangela Lecciso Valentina Salvestrini Grégory Verdeil Julien Racle Cristina Papayannidis Hideaki Morita Irene Pizzitola Camille Grandclément Perrine Bohner Elena Bruni Mukul Girotra Rani Pallavi Paolo Falvo Elisabeth Oppliger Leibundgut Gabriela M. Baerlocher Carmelo Carlo-Stella Daniela Taurino Armando Santoro Orietta Spinelli Alessandro Rambaldi Emanuela Giarin Giuseppe Basso Cristina Tresoldi Fabio Ciceri David Gfeller Cezmi A. Akdis Luca Mazzarella Saverio Minucci Pier Giuseppe Pelicci Emanuela Marcenaro Andrew N. J. McKenzie Dominique Vanhecke George Coukos Domenico Mavilio Antonio Curti Laurent Derré Camilla Jandus Tumour-derived PGD2 and NKp30-B7H6 engagement drives an immunosuppressive ILC2-MDSC axis |
description |
Group 2 innate lymphoid cells (ILC2s) modulate inflammatory and allergic responses, but their function in cancer immunity is still unclear. Here the authors show that, in acute promyelocytic leukaemia, tumour-activated ILC2s secrete IL-13 to induce myeloid-derived suppressor cells and support tumour growth. |
format |
article |
author |
Sara Trabanelli Mathieu F. Chevalier Amaia Martinez-Usatorre Alejandra Gomez-Cadena Bérengère Salomé Mariangela Lecciso Valentina Salvestrini Grégory Verdeil Julien Racle Cristina Papayannidis Hideaki Morita Irene Pizzitola Camille Grandclément Perrine Bohner Elena Bruni Mukul Girotra Rani Pallavi Paolo Falvo Elisabeth Oppliger Leibundgut Gabriela M. Baerlocher Carmelo Carlo-Stella Daniela Taurino Armando Santoro Orietta Spinelli Alessandro Rambaldi Emanuela Giarin Giuseppe Basso Cristina Tresoldi Fabio Ciceri David Gfeller Cezmi A. Akdis Luca Mazzarella Saverio Minucci Pier Giuseppe Pelicci Emanuela Marcenaro Andrew N. J. McKenzie Dominique Vanhecke George Coukos Domenico Mavilio Antonio Curti Laurent Derré Camilla Jandus |
author_facet |
Sara Trabanelli Mathieu F. Chevalier Amaia Martinez-Usatorre Alejandra Gomez-Cadena Bérengère Salomé Mariangela Lecciso Valentina Salvestrini Grégory Verdeil Julien Racle Cristina Papayannidis Hideaki Morita Irene Pizzitola Camille Grandclément Perrine Bohner Elena Bruni Mukul Girotra Rani Pallavi Paolo Falvo Elisabeth Oppliger Leibundgut Gabriela M. Baerlocher Carmelo Carlo-Stella Daniela Taurino Armando Santoro Orietta Spinelli Alessandro Rambaldi Emanuela Giarin Giuseppe Basso Cristina Tresoldi Fabio Ciceri David Gfeller Cezmi A. Akdis Luca Mazzarella Saverio Minucci Pier Giuseppe Pelicci Emanuela Marcenaro Andrew N. J. McKenzie Dominique Vanhecke George Coukos Domenico Mavilio Antonio Curti Laurent Derré Camilla Jandus |
author_sort |
Sara Trabanelli |
title |
Tumour-derived PGD2 and NKp30-B7H6 engagement drives an immunosuppressive ILC2-MDSC axis |
title_short |
Tumour-derived PGD2 and NKp30-B7H6 engagement drives an immunosuppressive ILC2-MDSC axis |
title_full |
Tumour-derived PGD2 and NKp30-B7H6 engagement drives an immunosuppressive ILC2-MDSC axis |
title_fullStr |
Tumour-derived PGD2 and NKp30-B7H6 engagement drives an immunosuppressive ILC2-MDSC axis |
title_full_unstemmed |
Tumour-derived PGD2 and NKp30-B7H6 engagement drives an immunosuppressive ILC2-MDSC axis |
title_sort |
tumour-derived pgd2 and nkp30-b7h6 engagement drives an immunosuppressive ilc2-mdsc axis |
publisher |
Nature Portfolio |
publishDate |
2017 |
url |
https://doaj.org/article/acd6edf30f5b42e78199d6bb93f923c9 |
work_keys_str_mv |
AT saratrabanelli tumourderivedpgd2andnkp30b7h6engagementdrivesanimmunosuppressiveilc2mdscaxis AT mathieufchevalier tumourderivedpgd2andnkp30b7h6engagementdrivesanimmunosuppressiveilc2mdscaxis AT amaiamartinezusatorre tumourderivedpgd2andnkp30b7h6engagementdrivesanimmunosuppressiveilc2mdscaxis AT alejandragomezcadena tumourderivedpgd2andnkp30b7h6engagementdrivesanimmunosuppressiveilc2mdscaxis AT berengeresalome tumourderivedpgd2andnkp30b7h6engagementdrivesanimmunosuppressiveilc2mdscaxis AT mariangelalecciso tumourderivedpgd2andnkp30b7h6engagementdrivesanimmunosuppressiveilc2mdscaxis AT valentinasalvestrini tumourderivedpgd2andnkp30b7h6engagementdrivesanimmunosuppressiveilc2mdscaxis AT gregoryverdeil tumourderivedpgd2andnkp30b7h6engagementdrivesanimmunosuppressiveilc2mdscaxis AT julienracle tumourderivedpgd2andnkp30b7h6engagementdrivesanimmunosuppressiveilc2mdscaxis AT cristinapapayannidis tumourderivedpgd2andnkp30b7h6engagementdrivesanimmunosuppressiveilc2mdscaxis AT hideakimorita tumourderivedpgd2andnkp30b7h6engagementdrivesanimmunosuppressiveilc2mdscaxis AT irenepizzitola tumourderivedpgd2andnkp30b7h6engagementdrivesanimmunosuppressiveilc2mdscaxis AT camillegrandclement tumourderivedpgd2andnkp30b7h6engagementdrivesanimmunosuppressiveilc2mdscaxis AT perrinebohner tumourderivedpgd2andnkp30b7h6engagementdrivesanimmunosuppressiveilc2mdscaxis AT elenabruni tumourderivedpgd2andnkp30b7h6engagementdrivesanimmunosuppressiveilc2mdscaxis AT mukulgirotra tumourderivedpgd2andnkp30b7h6engagementdrivesanimmunosuppressiveilc2mdscaxis AT ranipallavi tumourderivedpgd2andnkp30b7h6engagementdrivesanimmunosuppressiveilc2mdscaxis AT paolofalvo tumourderivedpgd2andnkp30b7h6engagementdrivesanimmunosuppressiveilc2mdscaxis AT elisabethoppligerleibundgut tumourderivedpgd2andnkp30b7h6engagementdrivesanimmunosuppressiveilc2mdscaxis AT gabrielambaerlocher tumourderivedpgd2andnkp30b7h6engagementdrivesanimmunosuppressiveilc2mdscaxis AT carmelocarlostella tumourderivedpgd2andnkp30b7h6engagementdrivesanimmunosuppressiveilc2mdscaxis AT danielataurino tumourderivedpgd2andnkp30b7h6engagementdrivesanimmunosuppressiveilc2mdscaxis AT armandosantoro tumourderivedpgd2andnkp30b7h6engagementdrivesanimmunosuppressiveilc2mdscaxis AT oriettaspinelli tumourderivedpgd2andnkp30b7h6engagementdrivesanimmunosuppressiveilc2mdscaxis AT alessandrorambaldi tumourderivedpgd2andnkp30b7h6engagementdrivesanimmunosuppressiveilc2mdscaxis AT emanuelagiarin tumourderivedpgd2andnkp30b7h6engagementdrivesanimmunosuppressiveilc2mdscaxis AT giuseppebasso tumourderivedpgd2andnkp30b7h6engagementdrivesanimmunosuppressiveilc2mdscaxis AT cristinatresoldi tumourderivedpgd2andnkp30b7h6engagementdrivesanimmunosuppressiveilc2mdscaxis AT fabiociceri tumourderivedpgd2andnkp30b7h6engagementdrivesanimmunosuppressiveilc2mdscaxis AT davidgfeller tumourderivedpgd2andnkp30b7h6engagementdrivesanimmunosuppressiveilc2mdscaxis AT cezmiaakdis tumourderivedpgd2andnkp30b7h6engagementdrivesanimmunosuppressiveilc2mdscaxis AT lucamazzarella tumourderivedpgd2andnkp30b7h6engagementdrivesanimmunosuppressiveilc2mdscaxis AT saveriominucci tumourderivedpgd2andnkp30b7h6engagementdrivesanimmunosuppressiveilc2mdscaxis AT piergiuseppepelicci tumourderivedpgd2andnkp30b7h6engagementdrivesanimmunosuppressiveilc2mdscaxis AT emanuelamarcenaro tumourderivedpgd2andnkp30b7h6engagementdrivesanimmunosuppressiveilc2mdscaxis AT andrewnjmckenzie tumourderivedpgd2andnkp30b7h6engagementdrivesanimmunosuppressiveilc2mdscaxis AT dominiquevanhecke tumourderivedpgd2andnkp30b7h6engagementdrivesanimmunosuppressiveilc2mdscaxis AT georgecoukos tumourderivedpgd2andnkp30b7h6engagementdrivesanimmunosuppressiveilc2mdscaxis AT domenicomavilio tumourderivedpgd2andnkp30b7h6engagementdrivesanimmunosuppressiveilc2mdscaxis AT antoniocurti tumourderivedpgd2andnkp30b7h6engagementdrivesanimmunosuppressiveilc2mdscaxis AT laurentderre tumourderivedpgd2andnkp30b7h6engagementdrivesanimmunosuppressiveilc2mdscaxis AT camillajandus tumourderivedpgd2andnkp30b7h6engagementdrivesanimmunosuppressiveilc2mdscaxis |
_version_ |
1718382168187600896 |